Warrior Met Coal LLC(HCC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HCC Warrior Met Coal LLC

Post-Mkt 12-11 16:53:48 EST

84.12

+3.83

+4.77%

盘后83.50

-0.62-0.74%

16:44 EST

High84.71	Low79.82	Vol765.51K
Open79.83	D1 Closing80.29	Amplitude6.09%
Mkt Cap4.42B	Tradable Cap4.33B	Total Shares52.57M
T/O64.19M	T/O Rate1.49%	Tradable Shares51.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HCC","market":"US","secType":"STK","nameCN":"Warrior Met Coal LLC","latestPrice":84.12,"timestamp":1765486800000,"preClose":80.29,"halted":0,"volume":765512,"hourTrading":{"tag":"盘后","latestPrice":83.5,"preClose":84.12,"latestTime":"16:44 EST","volume":20204,"amount":1699554.4187999999,"timestamp":1765489490943},"delay":0,"floatShares":51466215,"shares":52570156,"eps":0.669006,"marketStatus":"Post-Mkt","change":3.83,"latestTime":"12-11 16:53:48 EST","open":79.83,"high":84.71,"low":79.82,"amount":64193681.40372,"amplitude":0.060904,"askPrice":92.26,"askSize":100,"bidPrice":76.37,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.669006,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":720248400000,"exchange":"NYSE","adjPreClose":80.29,"dividendRate":0.003804,"preHourTrading":{"tag":"盘前","latestPrice":80.29,"preClose":80.29,"latestTime":"09:29 EST","volume":120,"amount":9598.7004,"timestamp":1765463342962},"postHourTrading":{"tag":"盘后","latestPrice":83.5,"preClose":84.12,"latestTime":"16:44 EST","volume":20204,"amount":1699554.4187999999,"timestamp":1765489490943},"volumeRatio":1.26531,"impliedVol":0.4557,"impliedVolPercentile":0.06},"requestUrl":"/m/hq/s/HCC/wiki","defaultTab":"wiki","newsList":[{"id":"2590368224","title":"Discover 3 Stocks Priced Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2590368224","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590368224?lang=en_us&edition=fundamental","pubTime":"2025-12-09 01:08","pubTimestamp":1765213700,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a period of volatility with major indices like the Dow Jones and S&P 500 experiencing fluctuations ahead of a critical Federal Reserve decision on interest rates, investors are keenly watching for opportunities amidst these shifts. In this environment, identifying stocks that are priced below their estimated value can offer potential advantages, as they may present opportunities for growth when market conditions stabilize or improve.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551737-choice2-main-header/1585186740457","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551737-choice2-main-header/1585186740457"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-mrp/millrose-properties/news/discover-3-stocks-priced-below-estimated-value","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-mrp/millrose-properties/news/discover-3-stocks-priced-below-estimated-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4006","BK4082","LU0266013472.USD","LU1169589451.USD","LU2211815571.USD","BK4551","BK4220","LU1323610961.USD","IE00BMPRXN33.USD","LU0106831901.USD","BK4234","BK4211","BK4539","LU2125909593.SGD","BK4504","BK4198","MRP","BK4526","LU1169590202.USD","LU1668664300.SGD","LU1861217088.USD","IE00BMPRXR70.SGD","BK4023","BK4150","BK4107","HCC","SBET","BK7078","LU2125909247.SGD","SG9999004303.SGD","LU0354030511.USD","LU0348766576.USD","LU0348767384.USD","LU1861220207.SGD","BK4610","SGXZ23171101.USD","BK4166","BK4121","BK4548","BK4534","BK4588","LU2360107671.USD","LU1923622614.USD","LU0354030438.USD","BK4077","LU1791807156.HKD","LU2433249047.HKD"],"gpt_icon":1},{"id":"2589380458","title":"Warrior Met Coal Inc : Jefferies Raises Target Price to $95 From $85","url":"https://stock-news.laohu8.com/highlight/detail?id=2589380458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589380458?lang=en_us&edition=fundamental","pubTime":"2025-12-08 15:41","pubTimestamp":1765179685,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE0FM:14","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HCC","BK4006"],"gpt_icon":0},{"id":"2589382089","title":"U.S. RESEARCH ROUNDUP- Apple, Cooper Companies, Sandisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2589382089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589382089?lang=en_us&edition=fundamental","pubTime":"2025-12-08 15:19","pubTimestamp":1765178368,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Apple, Cooper Companies, Sandisk Dec 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, Coo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4N3XE0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLD","MSBI","PAYX","LU1235294995.USD","LU1280957306.USD","AVAV","NEM","ENPH","LU0980610538.SGD","COO","BHP.AU","AAPL","LU0289960550.SGD","BK4142","LU1935043536.SGD","JKHY","KNF","SNDK","RIO.UK","PWR","VMC","AA","IE","SG9999014914.USD","MLM","SINT","BK4231","MACW.SI","ELS","WDC","GEHC","ORCL","VSCO","IE00B775H168.HKD","SAIC","PRIM","VIK","WPC","JHX","LU2271345857.HKD","LU0823414551.USD","FCX","AIM","FVR","BMI","LU2430703095.HKD","HCC","CRC","LU0788109121.HKD","RIO.AU"],"gpt_icon":1},{"id":"2589874529","title":"The Bull Case For Warrior Met Coal (HCC) Could Change Following Broad-Based Surge In Steelmaking Coal Demand - Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2589874529","media":"Simply Wall St.","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589874529?lang=en_us&edition=fundamental","pubTime":"2025-12-07 18:13","pubTimestamp":1765102431,"startTime":"0","endTime":"0","summary":"In recent days, Warrior Met Coal has benefited from stronger global demand for steelmaking coal, as infrastructure and manufacturing activity picked up across Europe, South America, and Asia. \nThis demand upswing highlights how the company’s focus on metallurgical coal and operational efficiency could be increasingly important for steel producers seeking reliable supply. \nAgainst this backdrop of rising metallurgical coal demand, we’ll explore how this trend may influence Warrior Met Coal’s...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/the-bull-case-for-warrior-met-coal-hcc-could-change-followin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/the-bull-case-for-warrior-met-coal-hcc-could-change-followin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCC","BK4006"],"gpt_icon":0},{"id":"2589841767","title":"Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2589841767","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589841767?lang=en_us&edition=fundamental","pubTime":"2025-12-06 11:11","pubTimestamp":1764990660,"startTime":"0","endTime":"0","summary":"Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/06/3201030/0/en/Toripalimab-Presents-Long-Term-Survival-Benefits-as-1st-line-Treatment-for-Advanced-Nasopharyngeal-Carcinoma-and-Esophageal-Squamous-Cell-Carcinoma-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","IE00B19Z4B17.USD","LU0053671581.USD","LU0054578231.USD","LU1815336091.USD","RCC","AEIS","GP","HCC","BK4195","BK4161","IE00B7SZL793.SGD","ITT","OS","IE0031619046.USD","BK4097","BK4149","PFS","IE00B66KJ199.SGD","LU0757428866.USD","BK4157","BK4006","ORR"],"gpt_icon":0},{"id":"2588704316","title":"Lyft And 2 Other Stocks That May Be Trading Below Fair Value Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704316","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704316?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:07","pubTimestamp":1764760072,"startTime":"0","endTime":"0","summary":"As of early December 2025, U.S. markets have shown resilience with major indexes closing higher amid a rebound in tech and crypto-related stocks. This environment presents opportunities for investors to explore stocks that may be trading below their fair value estimates, such as Lyft and others, by focusing on fundamental strengths and market positioning amidst the current economic landscape.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-estc/elastic/news/lyft-and-2-other-stocks-that-may-be-trading-below-fair-value","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-estc/elastic/news/lyft-and-2-other-stocks-that-may-be-trading-below-fair-value","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2211815571.USD","LU2098885051.SGD","BK4150","BK4022","IE00BMPRXN33.USD","BUSE","SGHC","BK4507","DXCM","BK4585","IE00BMPRXR70.SGD","ASIC","BK4198","FRSH","LU0053671581.USD","LU1323610961.USD","BK4121","ROKU","BK4608","LU1169589451.USD","BULL","LU1169590202.USD","BK4082","BK4534","BK4107","BK4108","BK4548","BK4588","BLFS","HCC","LU1861558580.USD","LU2433249047.HKD","LU1861559042.SGD","BK4524","BK4023","LU0354030511.USD","LYFT","LU0354030438.USD","ESTC","BK4613","LU0054578231.USD","BK4006","BK4230","BK4504","LU0266013472.USD","LU1923622614.USD","LU2125909247.SGD","LU2125909593.SGD","SHC","BK4211"],"gpt_icon":0},{"id":"2588164061","title":"Zymeworks Announces Participation in Upcoming Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2588164061","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588164061?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:05","pubTimestamp":1764709500,"startTime":"0","endTime":"0","summary":" Late-breaking HERIZON-GEA-01 presentation at ASCO GI highlights the expanding clinical profile of Ziihera across HER2-driven gastrointestinal cancers by partner Jazz  Zymeworks to present a Trial-in-","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3198428/0/en/Zymeworks-Announces-Participation-in-Upcoming-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","ET","BK4561","BK4006","ADC","BTC","BK4144","BK4581","BK4166","BK4080","HCC","BK4231","BK4585","OS","BK4097","BK4588","PT"],"gpt_icon":0},{"id":"2588706177","title":"3 Prominent Stocks Estimated To Be Undervalued By At Least 40.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706177","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588706177?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:08","pubTimestamp":1764608885,"startTime":"0","endTime":"0","summary":"As December begins, major U.S. stock indexes have slipped, with big tech and crypto-tied shares experiencing declines amid a risk-off sentiment in the market. In this environment, identifying undervalued stocks can be crucial for investors looking to capitalize on potential opportunities that may arise from current market fluctuations.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/253891410-main-header/1756256225781","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/253891410-main-header/1756256225781"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-team/atlassian/news/3-prominent-stocks-estimated-to-be-undervalued-by-at-least-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-team/atlassian/news/3-prominent-stocks-estimated-to-be-undervalued-by-at-least-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","LU0053671581.USD","NIC.AU","LU0029874061.USD","SHC","DXCM","LU0128526141.USD","LU1923622291.USD","NIC","LU2211817866.USD","FRSH","LU0154245756.USD","LU2125909593.SGD","BK4566","LU0154245673.USD","ASIC","BK4107","BK4082","BK4613","LU0054578231.USD","LU0354030438.USD","LU0354030511.USD","TEAM","BK4608","IE0009356076.USD","BK4023","HBAN","HCC","BK4127","ESTC","BK4532","CELH","LU2065731478.USD","BK4588","BK4561","LU2098885051.SGD","LU1720051017.SGD","LU1923622614.USD","BULL","LU2125909759.SGD","BK4534","LU2357305700.SGD","LU2433249047.HKD","LU0266013472.USD","LU1323610961.USD","IE00BMPRXR70.SGD","BK4504","BK7095","BUSE","PERF"],"gpt_icon":0},{"id":"2586203394","title":"How Investors May Respond To Warrior Met Coal (HCC) Surpassing Q3 Estimates and Gaining Analyst Interest","url":"https://stock-news.laohu8.com/highlight/detail?id=2586203394","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586203394?lang=en_us&edition=fundamental","pubTime":"2025-11-28 10:28","pubTimestamp":1764296898,"startTime":"0","endTime":"0","summary":"In the past week, Warrior Met Coal reported significantly better-than-expected third-quarter results, attracting updated analyst coverage and refined outlooks from several major firms, including UBS and Texas Capital Securities.\nThis surge in analyst attention highlights both operational performance improvements and a shift in sentiment toward key projects like Blue Creek, which is now considered fully de-risked.\nWe’ll examine how strong quarterly earnings and positive analyst commentary...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/how-investors-may-respond-to-warrior-met-coal-hcc-surpassing","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-hcc/warrior-met-coal/news/how-investors-may-respond-to-warrior-met-coal-hcc-surpassing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4006","BK4211","HCC"],"gpt_icon":0},{"id":"2586645251","title":"Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586645251","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586645251?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:00","pubTimestamp":1764158400,"startTime":"0","endTime":"0","summary":"RAMAT GAN, Israel, Nov.  26, 2025  (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195022/0/en/Can-Fite-s-Latest-Developments-of-its-Advanced-Stage-Drug-Pipeline-will-be-Presented-at-Noble-Capital-Markets-21st-Annual-Emerging-Growth-Equity-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","SSI","BK4585","BK4006","BK4215","HCC","BK4588","NBL"],"gpt_icon":0},{"id":"2586547165","title":"Warrior Met Coal (HCC) Receives a New Rating from Texas Capital Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586547165?lang=en_us&edition=fundamental","pubTime":"2025-11-25 22:35","pubTimestamp":1764081338,"startTime":"0","endTime":"0","summary":"Texas Capital Securities analyst initiated coverage with a Buy rating on Warrior Met Coal today and set a price target of $75.00. Currently, the an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/warrior-met-coal-hcc-receives-a-new-rating-from-texas-capital-securities-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/warrior-met-coal-hcc-receives-a-new-rating-from-texas-capital-securities-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCC"],"gpt_icon":0},{"id":"1118435898","title":"HENLIUS (02696): First Patient Dosed in China for International Phase 1 Clinical Study of HLX13 (Ipilimumab Biosimilar) in First-Line Treatment of Unresectable Hepatocellular Carcinoma (HCC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1118435898","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118435898?lang=en_us&edition=fundamental","pubTime":"2025-11-25 16:36","pubTimestamp":1764059807,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) announced that the first patient in China has been dosed in its international multicenter Phase 1 clinical study for HLX13 (recombinant fully human anti-CTLA-4 monoclonal antibody...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HK0000165453.HKD","HCC","02696","BK1161"],"gpt_icon":0},{"id":"2585493908","title":"Warrior Met Coal Is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2585493908","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585493908?lang=en_us&edition=fundamental","pubTime":"2025-11-24 23:06","pubTimestamp":1763996760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HCC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 24, 2025 10:06 ET (15:06 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCC","BK4006"],"gpt_icon":0},{"id":"2585671834","title":"UBS Adjusts Price Target on Warrior Met Coal to $80 From $75, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2585671834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585671834?lang=en_us&edition=fundamental","pubTime":"2025-11-24 21:40","pubTimestamp":1763991642,"startTime":"0","endTime":"0","summary":"Warrior Met Coal (HCC) has an average rating of overweight and mean price target of $82.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2585619504","title":"Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2585619504","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585619504?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985600,"startTime":"0","endTime":"0","summary":"Namodenoson, a Phase III cancer drug has strong potential in veterinary oncology, a market projected to reach $3.1 billion by 2030 Piclidenoson is currently in development for the treatment of osteoar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193378/0/en/Can-Fite-to-Advance-New-Veterinary-Partnership-Opportunities-for-Namodenoson-at-the-BioFIT-2025-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2585466086","title":"Warrior Met Coal Inc : UBS Raises Target Price to $80 From $75","url":"https://stock-news.laohu8.com/highlight/detail?id=2585466086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585466086?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:29","pubTimestamp":1763983752,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X008H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2584934116","title":"Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer Patient Treated with Namodenoson","url":"https://stock-news.laohu8.com/highlight/detail?id=2584934116","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584934116?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:00","pubTimestamp":1763467200,"startTime":"0","endTime":"0","summary":"Pivotal Phase III liver cancer study enrolling in Europe and Israel RAMAT GAN, Israel, Nov.  18, 2025  (GLOBE NEWSWIRE) --  Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/18/3189858/0/en/Can-Fite-9-Year-Survival-with-Complete-Cure-in-an-Advanced-Liver-Cancer-Patient-Treated-with-Namodenoson.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4081","HCC","EMA"],"gpt_icon":0},{"id":"2584335621","title":"3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584335621","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584335621?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377680,"startTime":"0","endTime":"0","summary":"In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WIX","BUSE","LU2265009873.SGD","LU0511384066.AUD","LU0251142724.SGD","CRM","CRM.AU","CCNE","FITB","BK4588","LU0345780950.USD","LU2756315664.SGD","LU2458330243.SGD","HBAN","HCC","LU2210150020.SGD","WGS","LU0069063385.USD","HUBS","LU0820561818.USD","LU0943347566.SGD","KRMD","CNH","BK4527","LU0234570918.USD","LU0128526141.USD","LU1823568750.SGD","LU2361045086.USD","LU0109392836.USD","LU0251131958.USD","LU0719512351.SGD","LU2210149790.SGD","IE00BZ9MQY76.HKD","LU0289961442.SGD","LU0289739343.SGD","BK4207","LU0648001328.SGD","BK4196","BK4023","LU0353189680.USD","LU2361044949.HKD","TMDX","LU2095319765.USD","LU1267930490.SGD","LU2458330169.SGD","ONB","LU2361044865.SGD","ONON","BK4561","LU0353189763.USD"],"gpt_icon":0},{"id":"2583518680","title":"Warrior Met Coal Chief Accounting Officer Brian M. Chopin Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583518680","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583518680?lang=en_us&edition=fundamental","pubTime":"2025-11-15 06:53","pubTimestamp":1763160787,"startTime":"0","endTime":"0","summary":"Brian M. Chopin, Chief Accounting Officer of Warrior Met Coal Inc., reported a disposal of common shares of Warrior Met Coal Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Warrior Met Coal Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL5mW7tV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Warrior Met Coal Chief Accounting Officer Brian M. Chopin Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","HCC"],"gpt_icon":0},{"id":"2583904511","title":"Press Release: Tvardi Therapeutics Announces Third Quarter 2025 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583904511","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583904511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067660,"startTime":"0","endTime":"0","summary":"On track for topline data from Phase 2 trial of TTI-101 in hepatocellular carcinoma  in H1 2026. Results from healthy volunteer study of its next-generation STAT3 inhibitor, TTI-109, expected in H1 2026. Tvardi Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat brosis-driven diseases, today announced its nancial and operating results for the third quarter ended September 30, 2025, and provided a business update.--  Continued to progress its Phase 2 study of TTI-101 in HCC, with topline. TTI-109, is in effect and that a healthy volunteer study has been. \"To that end, we eagerly await data from our ongoing Phase 2 REVERT Liver Cancer trial in the first half of next year. Interim results from this study have already shown clinically meaningful activity of TTI-101 both as monotherapy and in combination with established anti-cancer agents across treatment lines.Phase 1b/2 clinical tria","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","HCC","LENZ","BK4139","BK4006","TVRD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.warriormetcoal.com","stockEarnings":[{"period":"1week","weight":-0.0317},{"period":"1month","weight":-0.0251},{"period":"3month","weight":0.3556},{"period":"6month","weight":0.716},{"period":"1year","weight":0.2454},{"period":"ytd","weight":0.4803}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Warrior Met Coal, Inc. produces and exports non-thermal metallurgical coal for the steel industry. It operates two underground mines located in Alabama. The company sells its metallurgical coal to a customer base of blast furnace steel producers located primarily in Europe, South America, and Asia. It also sells natural gas, which is extracted as a byproduct from coal production. Warrior Met Coal, Inc. was incorporated in 2015 and is headquartered in Brookwood, Alabama.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.051754},{"month":2,"riseRate":0.5,"avgChangeRate":-0.010008},{"month":3,"riseRate":0.375,"avgChangeRate":-0.047162},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00691},{"month":5,"riseRate":0.444444,"avgChangeRate":0.012171},{"month":6,"riseRate":0.666667,"avgChangeRate":0.009594},{"month":7,"riseRate":0.777778,"avgChangeRate":0.07587},{"month":8,"riseRate":0.444444,"avgChangeRate":0.020482},{"month":9,"riseRate":0.666667,"avgChangeRate":0.034825},{"month":10,"riseRate":0.555556,"avgChangeRate":0.03995},{"month":11,"riseRate":0.666667,"avgChangeRate":0.081356},{"month":12,"riseRate":0.777778,"avgChangeRate":0.047294}],"exchange":"NYSE","name":"Warrior Met Coal LLC","nameEN":"Warrior Met Coal LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Warrior Met Coal LLC(HCC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Warrior Met Coal LLC(HCC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Warrior Met Coal LLC,HCC,Warrior Met Coal LLC股票,Warrior Met Coal LLC股票老虎,Warrior Met Coal LLC股票老虎国际,Warrior Met Coal LLC行情,Warrior Met Coal LLC股票行情,Warrior Met Coal LLC股价,Warrior Met Coal LLC股市,Warrior Met Coal LLC股票价格,Warrior Met Coal LLC股票交易,Warrior Met Coal LLC股票购买,Warrior Met Coal LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Warrior Met Coal LLC(HCC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Warrior Met Coal LLC(HCC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction